Administration, Inhalation

"Administration, Inhalation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

The administration of drugs by the respiratory route. It includes insufflation into the respiratory tract.

Descriptor ID	D000280
MeSH Number(s)	E02.319.267.050
Concept/Terms	Administration, Inhalation Administration, Inhalation Drug Administration, Respiratory Administration, Respiratory Drug Respiratory Drug Administration Inhalation Drug Administration Drug Administration, Inhalation Administration, Inhalation Drug Inhalation Administration Drug Aerosol Therapy Drug Aerosol Therapy Aerosol Therapy, Drug Therapy, Drug Aerosol Drug Therapy, Aerosol Aerosol Drug Therapy Therapy, Aerosol Drug Inhalation of Drugs Inhalation of Drugs

Below are MeSH descriptors whose meaning is more general than "Administration, Inhalation".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Therapeutics [E02]
Drug Therapy [E02.319]
Drug Administration Routes [E02.319.267]
Administration, Inhalation [E02.319.267.050]

Below are MeSH descriptors whose meaning is related to "Administration, Inhalation".

Below are MeSH descriptors whose meaning is more specific than "Administration, Inhalation".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Administration, Inhalation" by people in this website by year, and whether "Administration, Inhalation" was a major or minor topic of these publications.

Bar chart showing 97 publications over 26 distinct years, with a maximum of 9 publications in 2020 and 2022

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	0	1	1
1997	0	2	2
1998	0	1	1
1999	0	2	2
2000	0	3	3
2001	0	1	1
2002	0	2	2
2004	0	2	2
2006	0	5	5
2007	0	2	2
2008	0	4	4
2009	0	5	5
2010	1	5	6
2011	0	7	7
2012	0	6	6
2014	0	2	2
2015	1	3	4
2016	0	3	3
2017	0	3	3
2018	1	5	6
2019	0	6	6
2020	0	9	9
2021	0	3	3
2022	0	9	9
2023	0	1	1
2025	0	2	2

Below are the most recent publications written about "Administration, Inhalation" by people in Profiles.

Sciurba FC, Criner GJ, Christenson SA, Martinez FJ, Papi A, Roche N, Bourbeau J, Korn S, Bafadhel M, Han MK, Kolterer S, Miller K, Mouneimne D, Fletcher J, Mayer B, Min J, Pavord ID. Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype. N Engl J Med. 2025 May 01; 392(17):1710-1720.

View in: PubMed
Singh D, Martinez FJ, Hurst JR, Han MK, Gale CP, Fredriksson M, Kisielewicz D, Mushunje A, Movitz C, Ojili N, Parikh H, Arya N, Bowen K, Patel M. Effect of Triple Therapy on Cardiovascular and Severe Cardiopulmonary Events in Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis of a Randomized, Double-Blind, Phase 3 Clinical Trial (ETHOS). Am J Respir Crit Care Med. 2025 Feb; 211(2):205-214.

View in: PubMed
Rabe KF, Rennard S, Martinez FJ, Celli BR, Singh D, Papi A, Bafadhel M, Heble J, Radwan A, Soler X, Jacob Nara JA, Deniz Y, Rowe PJ. Targeting Type 2 Inflammation and Epithelial Alarmins in Chronic Obstructive Pulmonary Disease: A Biologics Outlook. Am J Respir Crit Care Med. 2023 08 15; 208(4):395-405.

View in: PubMed
Bardsley S, Criner GJ, Halpin DMG, Han MK, Hanania NA, Hill D, Lange P, Lipson DA, Martinez FJ, Midwinter D, Siler TM, Singh D, Wise RA, van Zyl-Smit RN, Berkman N. Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus dual therapy in current and former smokers with COPD: IMPACT trial post hoc analysis. Respir Med. 2022 12; 205:107040.

View in: PubMed
LeMaster WB, Quibrera PM, Couper D, Tashkin DP, Bleecker ER, Doerschuk CM, Ortega VE, Cooper C, Han MK, Woodruff PG, O'Neal WK, Anderson WH, Alexis NE, Bowler RP, Barr RG, Kaner RJ, Dransfield MT, Paine R, Kim V, Curtis JL, Martinez FJ, Hastie AT, Barjaktarevic I. Clinical Implications of Low Absolute Blood Eosinophil Count in the SPIROMICS COPD Cohort. Chest. 2023 03; 163(3):515-528.

View in: PubMed
Herrmann Z, Jaini P, Hsu J, Rush AJ. Two Cases Comparing the Presentations and Outcomes of Heroin-induced Toxic Leukoencephalopathy. J Psychiatr Pract. 2022 09 01; 28(5):426-430.

View in: PubMed
Thompson PJ, Criner GJ, Dransfield MT, Halpin DMG, Han MK, Lipson DA, Maghzal GJ, Martinez FJ, Midwinter D, Singh D, Tombs L, Wise RA. Effect of chronic mucus hypersecretion on treatment responses to inhaled therapies in patients with chronic obstructive pulmonary disease: Post hoc analysis of the IMPACT trial. Respirology. 2022 12; 27(12):1034-1044.

View in: PubMed
Bosch NA, Law AC, Vail EA, Gillmeyer KR, Gershengorn HB, Wunsch H, Walkey AJ. Inhaled Nitric Oxide vs?Epoprostenol During Acute Respiratory Failure: An Observational Target Trial Emulation. Chest. 2022 Dec; 162(6):1287-1296.

View in: PubMed
Gabrio A, Gunsoy NB, Baio G, Martin A, Paly VF, Risebrough N, Halpin DMG, Singh D, Wise RA, Han MK, Martinez FJ, Criner GJ, Martin N, Lipson DA, Ismaila AS. Single-Inhaler Triple Therapy in Patients with Advanced COPD: Bayesian Modeling of the Healthcare Resource Utilization Data and Associated Costs from the IMPACT Trial. Int J Chron Obstruct Pulmon Dis. 2022; 17:1633-1642.

View in: PubMed
Singh D, Agusti A, Martinez FJ, Papi A, Pavord ID, Wedzicha JA, Vogelmeier CF, Halpin DMG. Blood Eosinophils and Chronic Obstructive Pulmonary Disease: A Global Initiative for Chronic Obstructive Lung Disease Science Committee 2022 Review. Am J Respir Crit Care Med. 2022 07 01; 206(1):17-24.

View in: PubMed

People

Explore

Similar Concepts

Top Journals